Bellevue Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $14M | Sell |
|
|||||
|
2024
Q4 | $21.9M | Hold |
|
|||||
|
2024
Q3 | $16.4M | Hold |
|
|||||
|
2024
Q2 | $22.1M | Hold |
|
|||||
|
2024
Q1 | $26.7M | Buy |
|
|||||
|
2023
Q4 | $12.6M | Hold |
|
|||||
|
2023
Q3 | $4.12M | Sell |
|
|||||
|
2023
Q2 | $5.85M | Hold |
|
|||||
|
2023
Q1 | $6.69M | Sell |
|
|||||
|
2022
Q4 | $27M | Buy |
|
|||||
|
2022
Q3 | $28.3M | Sell |
|
|||||
|
2022
Q2 | $26.9M | Sell |
|
|||||
|
2022
Q1 | $19.9M | Sell |
|
|||||
|
2021
Q4 | $22.6M | Hold |
|
|||||
|
2021
Q3 | $54.5M | Hold |
|
|||||
|
2021
Q2 | $95.6M | Buy |
|
|||||
|
2021
Q1 | $112M | Sell |
|
|||||
|
2020
Q4 | $134M | Sell |
|
|||||
|
2020
Q3 | $203M | Buy |
|
|||||
|
2020
Q2 | $272M | Buy |
|
|||||
|
2020
Q1 | $159M | Buy |
|
|||||
|
2019
Q4 | $270M | Buy |
|
|||||
|
2019
Q3 | $155M | Buy |
|
|||||
|
2019
Q2 | $189M | Buy |
|
|||||
|
2019
Q1 | $19.9M | Buy |
|
|||||
|
2018
Q4 | $20.8M | Buy |
|
|||||
|
2018
Q3 | $17.4M | Buy |
|
|||||
|
2018
Q2 | $12.3M | Buy |
|
|||||
|
2018
Q1 | $12.5M | Buy |
|
|||||
|
2017
Q4 | $514K | Sell |
|
|||||
|
2017
Q3 | $401K | Hold |
|
|||||
|
2017
Q2 | $370K | Sell |
|
|||||
|
2017
Q1 | $1.13M | Sell |
|
|||||
|
2016
Q4 | $501K | Hold |
|
|||||
|
2016
Q3 | $554K | Hold |
|
|||||
|
2016
Q2 | $395K | Hold |
|
|||||
|
2016
Q1 | $676K | Buy |
|